uvstocks.io

Today’s CSR movers

SRE 4.1 ▲ 1.2

ES 3.0 ▲ 0.8

EIX 3.1 ▲ 0.8

AMZN 4.7 ▲ 0.1

GS 2.3 ▼ 0.8

WEC 2.6 ▼ 1.2

ETR 2.9 ▼ 1.2

C 2.8 ▼ 1.2

PCG 2.9 ▼ 1.2

FOX 2.4 ▼ 1.5

Health Care · NYSE NYSE · WAT

Waters Corporation

$357.54 -$11.08 -3.10% CLOSE 07.20.26 AFTER HOURS $357.54

Convergence score

4.0 / 5.0 STRONG BULLISH

+0.0 vs last report

Overall valuation

Overvalued

Aggregated across multiple horizons

Consensus target (12mo)

$408.96 +14.4%

Range $345.00 — $460.00

Sector

Health Care

NYSE · Tracked daily

Today's snapshot

Where the signals stand.

REPORT 07.20.26

UV Convergence Score

REPORT 07.20.26

4.0

/ 5.0

STRONG BULLISH

Consensus signal A

4.0

Consensus signal B

4.0

Consensus signal D

4.0

Rating trend signal

4.2

Analyst average

4.2

Multi-signal aggregate How CSR works →

Day Range

$357.04 – $367.87

52W Range

$275.05 – $414.15

Volume

627.1K

Avg Vol

1.0M

Mkt Cap

$35.11B

P/E

46.92

EPS (TTM)

$7.62

Div Yield

—

Beta

1.20

Today's convergence

Convergence score sits at 4.0 with overall valuation reading as overvalued. Drivers across the horizons inform the aggregate. Open the deep dives for valuation, analyst, or financial detail.

Valuation

Overvalued

CSR direction

STRONG BULLISH

Last close

$357.54

Sector

Health Care

Valuation

Three horizons

UPDATED 07.20.26

Short term

0–3 MO

No target Moderate Buy

Medium term

3–12 MO

$402+12.3% Buy

Long term

12–36 MO

$143.42-59.9% Overvalued

Open valuation →

Analysts

Coverage & consensus

4 PANELS

Mean target (12mo)

$408.96 +14.4%

RANGE $345.00 — $460.00

Analyst consensus

Consensus rating Buy

Blended score 4.1 / 5

Analysts tracked 93

Open analysts →

Financials

Key metrics

LATEST

P/E

46.92

EPS (TTM)

$7.62

Mkt Cap

$35.11B

Div Yield

—

Beta

1.20

52W Range

$275.05 – $414.15

Open financials →

Reports

Valuation breakdown

Three horizons, one consensus.

UPDATED 07.20.26

Short term

0–3 MO

Moderate Buy

Consensus target

No target available

Current analyst consensus rating from Barchart.

Medium term

3–12 MO

Buy

Consensus target

$402 +12.3%

RANGE $345 – $440

$345NOW $357.54$440

12-month analyst consensus target across covering brokerages.

Long term

12–36 MO

Overvalued

Consensus target

$143.42 -59.9%

UVStocks in-house sector-relative valuation model.

Signal breakdown

What’s driving the score.

EACH SIGNAL RATED 1.0 — 5.0

Top-level breakdown

Valuation:	PE Ratio: 46.92	PEG Ratio: -	DE Ratio: -
Free Cash Flow: $-502.37M	PB Ratio: -	PS Ratio: -	Dividend: -

Analyst coverage

Blended analyst consensus & targets.

4 PANELS · UPDATED 07.20.26

Analyst consensus RATING · SCORE · PANELS · ANALYSTS

Rating Blended score Panels Analysts

Buy 4.1 4 93

Price targets LOW · MEAN · MEDIAN · HIGH · UPSIDE

Coverage Low Mean Median High Upside

All panels $345.00 $408.96 $419.00 $460.00 +14.4%

Rating distribution STRONG BUY · BUY · HOLD · SELL · STRONG SELL

Coverage SB B H S SS

All panels 6 22 18 0 0

Rating trend CURRENT VS 1M / 2M / 3M

Period Rating Avg Analysts

Current Moderate Buy 4.17 23

1 Mo Ago Moderate Buy 4.14 21

2 Mo Ago Moderate Buy 4.20 20

3 Mo Ago Moderate Buy 4.14 21

Most recent analyst action LATEST DESK ACTION

Date

7/17/2026

Firm

Weiss Ratings

Action

Reiterated Rating

Rating

Hold (C)

Target

—

Full financial snapshot.

UPDATED 07.20.26

Quote snapshot 15 FIELDS

Prev Close

$368.98

Open

$367.48

Day Low

$357.04

Day High

$367.87

Bid

$345.90

Ask

$376.81

52W Low

$275.05

52W High

$414.15

50D Avg

$361.48

200D Avg

$351.87

Volume

627.1K

Avg Vol

1.0M

10D Avg Vol

653.9K

52W Change

31.00%

S&P 52W Change

18.27%

Valuation ratios 10 FIELDS

P/E (TTM)

46.92

P/E (Fwd)

21.68

PEG (Fwd)

1.64

P/S

9.31

P/B

2.30

Book Value

$155.78

EV/Revenue

10.67

EV/EBITDA

35.46

Mkt Cap

35.11B

Enterprise Val

40.25B

Profitability & returns 6 FIELDS

Profit Margin

11.93%

Gross Margin

55.15%

Operating Margin

2.84%

EBITDA Margin

30.11%

Return on Assets

3.31%

Return on Equity

5.21%

Growth 3 FIELDS

Revenue Growth (YoY)

91.40%

Earnings Growth (YoY)

—

Earnings Growth (Q)

—

Balance sheet & cash flow 11 FIELDS

Total Revenue

3.77B

EBITDA

1.14B

Total Cash

462M

Total Debt

5.6B

Cash / Share

$4.71

Revenue / Share

$57.84

Free Cash Flow

-502.37M

Operating CF

389.56M

Debt / Equity

36.63

Current Ratio

1.79

Quick Ratio

0.97

Dividend 5 FIELDS

Fwd Dividend

—

Dividend Yield

—

Payout Ratio

0.00%

5Y Avg Yield

—

Ex-Div Date

1996-11-26

Share statistics 7 FIELDS

Shares Out

98.19M

Float

98M

Shares Short

3.7M

% Short of Float

3.77%

Short Ratio

3.72

% Held Insiders

0.10%

% Held Institutions

99.59%

Calendar & events 5 FIELDS

Next Earnings

2026-08-04

Fiscal Year End

2025-12-31

Most Recent Qtr

2026-04-04

Last Split

2:1

Split Date

2000-08-28

Company 2 FIELDS

Industry

Diagnostics & Research

Employees

16,000